Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Sciatica Acute, Lumbar Spinal Stenosis

In brief

The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about: * Amount and quality of pain * Interference with physical activity * Interference with sleep

Key facts

Study ID
NCT06157177
Run by
Primus Pharmaceuticals
People needed
50
Starts
2023-11-15
Expected to finish
2026-11-15
Last updated by the study team
2026-05-12

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.